Cohen Fred E

Cohen Fred E is listed in filings as Director at Kyverna Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including purchase activity. Recent filings connect the profile to Kyverna Therapeutics, Inc. (KYTX), Intellia Therapeutics, Inc. (NTLA), CareDx, Inc. (CDNA), and UroGen Pharma Ltd. (URGN). The current snapshot covers public activity from Jun 14, 2024 to May 29, 2026. Reported amounts are shown as $176.8K to $95.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.